Guest guest Posted January 21, 2000 Report Share Posted January 21, 2000 In a message dated 1/21/00 10:01:18 AM Pacific Standard Time, DSNurse@... writes: << The injectable vaccine, developed by Dr. Jonas Salk in the 1950s, relies on a killed virus. Salk had long insisted his vaccine was safer, but other scientists said it was not as effective at providing lifelong immunity. >>TxDarkKn adds: Virus Diseases Alert: Patients and laypersons looking for guidance among the target sources of this collection of links are strongly advised to review the information retrieved with their professional health care provider. http://www.mic.ki.se/Diseases/c2.html SV-40 http://www.ccid.org/addviruses/sv40.html ------------------------------------------------------------------------------ -- SV-40 is a small double stranded, circular DNA virus of rhesus monkey origin. It is closely related to JC and BK viruses of human origin. While BK virus may not cause human disease, JC virus can cause a very severe brain illness in HIV infected patients, that is called progressive multifocal leukoencephalopathy or PML. SV-40 is also distanly related to human papillomaviruses, some of which cause cervical cancers. SV-40 infection is now widespread within the human population almost certainly as a result of poliovaccine produced in rhesus monkey kidney cells during the 1950s. A recent study showed infection in 23% of blood samples from normal individuals. The virus can also be detected in sperm fluid and is likely to be passed congenitally to future generations (i et al. SV40 Early Region and Large T Antigen in Human Brain Tumors, Peripheral Blood Cells, and Sperm Fluids from Healthy Individuals. Cancer Research 56: 4820-4825, 1996). As the title indicates this paper also confirms previous reports that SV-40 is present in a significant proportion of human brain tumors. Other reports have shown SV-40 in human brain tumors, e.g. Bergsagel et al. New England Journal of Medicine 326: 988-993, 1992. SV-40 has also been detected in a high proportion of human mesotheliomas (Carbone et al. Oncogene 9: 1781-1790, 1994); and in bone tumors called osteogenic sarcomas (Carbone et al. Oncogene 1996). FDA has been reluctant to act on reports of SV-40 but will have to respond to forthcoming publications in the " New Yorker " and " Money " magazines. SV-40 contamination was detected in the rhesus monkey kidney cells used to make poliovaccine as early as 1960. A Federal employee, Dr. Bernice Eddy, decided on her own inititive, to test extracts from the monkey kidney cells used to make poliovaccine for possible cancer causing agents. She chose to use newborn hamsters since these animals developed tumors with a type of virus she and had discovered in mice and named polyoma virus. The inoculated hamsters developed tumors similar to those induced with polyoma virus. The results of Dr. Eddy's unauthorized testing was meet with the same scorn and indifference as her earlier warings that some of the initial lots of Salk vaccine retained live poliovirus. Again, frustrated by the unwillingness of her supervisors to act on her tumor findings, Dr. Eddy went around channels and disclosed her results in a 1990 scientific meeting. Her punishment was to be taken off poliovaccine safety testing and prohibited for over a year from submitting her work for publication. Dr. Eddy's findings did however leak out and were replicated by Drs. Sweet and Hilleman at Merck. Initially, Hilleman thought the SV-40 problem would apply mainly to the live polio vaccines developed by Dr. Sabin and used extensively in the Soviet Union. He even suggested that the Russians would be no threat at the upcoming 1962 Olympics because they would be dragging with tumors (The Health Century by Shorter). Unfortunately, it was soon realized that the polio vaccine developed by Dr. Salk was the more dangerous because the 1:4,000 dilution of formaldehyde, which barely inactivated the poliovirus, did not fully inactivate SV-40. Because the Salk vaccine was injected through the skin, it allowed the SV-40 a better chance to infect. To his credit, Dr. Hilleman repeatedly sounded warnings about the risks inherent in the use of monkey tissue for vaccine production. For example, he has made the following comments " ...use of tissues of wild-caught animals is just asking for trouble because of the lack of control and the known high proability for viral contamination. Monkeys are too expensive to be grown in specific pathogen-free colonies and, hence, the simple solution to the monkey problem is to eliminate the monkey " and also " The tissues of wild-caught animals, and certainly monkeys, are commonly infected with wild viruses. The simplest way to solve the monkey problem is to eliminate the monkeys and this is being done using diploid cells. Monkey tissues came into use by historic decisions to use monkey kidney to make poliovaccine. There is no need to continue using monkeys when acceptible alternatives are available. This advice was never taken especially in the face of pressure from Lederle/American Cyanamid to continue to use monkeys. The main result of finding SV-40 virus in rhesus monkeys was simply to switch poliovaccine production to African green monkeys. Existing stocks of SV-40 poliovaccines were not withdrawn from the market, nor was any effort made to suspend the military's use of adenoviral vaccines, also known to contain SV-40. Short termed follow studies on some of the children exposed to SV-40, to see if brain tumors had developed, satisfied those in charge of Public Safety, that no harm had been done. Since the hamster tumor model required virus exposure to newborn animals, Public Health officials should have predicted the need to maintain surveillance for the subsequent human generation. Now that evidence is accumulating that a problem exists, the continued reluctance of FDA to respond is, to say the least, disappointing. The overall story with SV-40 is being replicated with the resistance of FDA and of Industry to meaningly address the question of other monkey viruses having been transmitted to humans through poliovaccines. While the African green monkey is generally free of SV-40 virus, it does carry a number of viruses, including simian cytomegalovitrus (SCMV). As an aside, rhesus and not African green monkeys are used for testing the virulence of live polio vaccines, because even the control African green monkeys often show evidence of neural infection. In an effort to underscore, the need for a more responsive FDA, samples of a 1954 polio vaccine, held by Dr. Ratner, a Public Health official whose concerns about poliovaccine safety had been largely ignored, have been sent to investigators studying SV-40 to show how easy it is to detect contaminants using the PCR assay. This assays was not available in the 1950s, but now that it is, there is no excuse for not using it on polio and other vaccines to exclude contaminants including SCMV and related stealth viruses. A copy of Dr. Carbone's latest paper will be posted shortly. Additional information can also be found in the Handouts under Publications and Presentation section. For information on SV-40 testing please refer to the Clinical Laboratory. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 19, 2004 Report Share Posted May 19, 2004 that is just so much crap it makes me sick, here's the other side: IOM AND CDC COVER-UP: HOW FAR WILL THEY GO TO PROTECT TOXIC VACCINES? RIDDLED WITH CONFLICTS OF INTEREST, INSTITUTE OF MEDICINE RELEASES REPORT DERIVED FROM FLAWED DATA, SAYS NATIONAL AUTISM ASSOCIATION Washington, DC- A report released today has parents and researchers shocked at how far the Institute of Medicine (IOM) and Centers for Disease Control (CDC) will go to protect the reputation of the vaccination program. After CDC-funded hearings were held in front of an IOM panel on February 9th regarding the connection between vaccines and autism, IOM released its decision today by stating there is no connection, despite strong clinical evidence from accredited doctors and researchers that suggests otherwise. To reach their decision, the IOM relied heavily upon CDC’s Vaccine Safety Database (VSD) study published in the Journal of Pediatrics in November, 2003. Many critics have come forward questioning its validity. The study’s author, Dr. Verstraeten, works for a leading vaccine manufacturer. He also authored the first CDC VSD study in 2000, obtained through FOIA, which found a statistically significant link between thimerosal containing vaccines and thimerosal but the study was not released to the public. The National Autism Association (NAA), supporting families and physicians looking for effective treatments for autism and other neurodevelopmental disorders, says the report proves the IOM has not been able to divest itself from vaccine policies. And tragically, in doing so, they have failed society by their blindness to the issue at hand. “It appears the IOM’s admitted fear of an undermined vaccination program has led to this decision, not scientific evidence,†says Lori McIlwain, Executive Director of the National Autism Association. NAA states they are for safe vaccines and stand by the clinical evidence that was presented to the IOM from highly accredited researchers, along with medical records of affected children. “Thousands of parents have seen the regression of skills in their children following thimerosal-containing vaccines,†says Jo Pike President of the National Autism Association. “Many of these same children are progressing rapidly with biomedical interventions addressing mercury poisoning. The cause and effect should not be ignored,†she says. In their report, the IOM panel dismissed strong clinical and epidemiological evidence presented during the hearings. These studies include: Dr. Mark Geier and Geier presented epidemiological evidence that children who received thimerosal-containing vaccines were six times more likely to have autism than regular children. Mady Hornig, MD, showed mice that had been given thimerosal-containing vaccines and subsequently developed harmful repetitive behaviors similar to those of autism. Baskin, MD, showed the neurotoxic affects of ethylmercury and how such damage can lead to apoptosis of cells. Jeff Bradsteet, MD, showed that autistic children had six times more mercury in their bodies than age and vaccine-matched controls. Boyd Haley, MD, showed that autistic children have less mercury in their hair than controls hypothesizing that autistic children can not detoxify as easily as regular children. “The IOM took over 10 years to acknowledge Gulf War Syndrome and over 20 years to acknowledge Agent Orange poisoning,†says Bono, NAA Chairman. “We are asking the IOM to affirm the mass poisoning of thousands of children through mercury in their vaccines. We are confident that the truth will eventually come out and we will not be deterred until it does.†For more information, visit www.NationalAutism.org. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 29, 2004 Report Share Posted August 29, 2004 Click here for a print-friendly version Reported August 27, 2004 Needle-free Anthrax Vaccine Coming (Ivanhoe Newswire) -- A new anthrax vaccine may offer a faster and easier way to protect the general population and soldiers at war in the event of a deadly bioterror attack. Scientists with BD Technologies in North Carolina along with the U.S. Army Medical Research Institute of Infectious Disease have developed a powdered form of the vaccine that could potentially be inhaled through the nose, thus eliminating needle injections. The vaccine has not yet been tested in humans, but investigators say clinical trials could be possible within the next two to three years. In laboratory tests using rabbits exposed to a lethal dose of inhalation anthrax, nasal immunization with the powder resulted in an 83-percent to 100-percent survival rate. The results are similar to the protection offered by the injected formula. The new formulation is based on an anthrax recombinant protective antigen (rPA), a genetically engineered protein. Investigators say the powdered formula is more stable than the injected liquid version and can withstand wider temperature extremes, which allows it to be stockpiled for longer periods and in more extreme conditions without refrigeration. The standard delivery of anthrax vaccination using needles and syringes has several drawbacks when employed for mass vaccination, researchers add. These include accidental needlestick injury, the need for highly trained healthcare professionals, and painful injections. Anthrax vaccinations are now mandatory for military personnel sent to areas with high risk of exposure and recommended for other groups, including some laboratory and postal workers. This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/ .. SOURCE: The 228th National Meeting of the American Chemical Society in Philadelphia, Aug. 22-26, 2004 Related Articles in Archives: America's Medical Experts Prepare for Biological Warfare -- White Paper Vaccines of the Future MS Vaccine -- Full-Length Doctor's Interview Smallpox Protection Lymphoma Vaccine Nicotine Vaccine Needle-Free Flu Vaccine Smallpox Vaccine Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 25, 2005 Report Share Posted September 25, 2005 --- ZBirdBrain@... wrote: > From: ZBirdBrain@... > Date: Sun, 25 Sep 2005 09:49:06 EDT > Subject: Fwd: Vaccine News > Vaccinations-owner > > > > From: ZBirdBrain@... > Date: Sun, 25 Sep 2005 09:42:48 EDT > Subject: Vaccine News > ZBirdBrain@... > > Here's the latest news from Kris . If you > feel this information is > appropriate and of interest to your group please > feel free to post and > crosspost. > > Thank you, > Deb > *** > Greetings All!!! > > Important news for companion animal owners and > lovers (see below and > Flaim's 9/19/05 story Challenging the Rabies > Vaccine in Newsday > http://www.newsday.com/mynews/ny-lspets4432971sep19,0,1274963.column > ) -- permission is > granted to post and cross-post this message. Please > help to spread the word so > we can get these studies underway as soon as > possible. > > Regards, Kris > > MAINE TODAY > > (http://blogs.mainetoday.com/dogslife/002976.html) > > Press Release > The Rabies Challenge Fund > > World-renown vaccine research scientist and > practicing veterinarian, Dr. W. > Dodds of California, and pet vaccine disclosure > advocate, Kris L. > of Maine, have established The Rabies > Challenge Fund to raise money to fund > a 7 year rabies vaccine challenge study in the > United States. > > In addition to the challenge study, the fund will > finance a study of the > adjuvants used in veterinary rabies vaccines and > establish a rabies vaccine > adverse reaction reporting system. > > Rabies vaccination is the one immunization required > by law across the country > for domestic dogs and cats. Researchers believe > this vaccine causes the most > and worst adverse reactions in animals. The Rabies > Challenge Fund has been > founded to improve the safety of rabies vaccines and > to determine, by > challenge, if they confer immunity for 5, 6, or 7 > years. > > The Rabies Challenge Fund's first official sponsors > are Deb Odom (Florida) > and Dawn (Arizona), who have committed to > donating a portion of the > proceeds from the sale of their pet vaccine informed > consent posters and > informational flyers. > > > Donations can be sent to THE RABIES CHALLENGE FUND, > c/o Hemopet, 11330 Markon > Drive, Garden Grove, CA 92841. > > Rabies Challenge Fund poster designed by fund > sponsor Deb Odom is accessible > at > (http://www.zbirdbrain.com/PetAdvocatesTownHallCisSupport.htm) > > > In addition to this news we are also kicking off the > National Pet Health > Awareness Campaign. New Pet Health Awareness Poster > designs are available and can > be used on pet related websites at no charge. > Information can be found at > (http://www.zbirdbrain.com/PetAdvocatesTownHallCISPics.htm) > and free banner > artwork (dog and cat) is available for websites. > > 'Fear not the path of truth for the lack of people walking on it.' - Bobby Kennedy http://www.livejournal.com/users/lady_karelia __________________________________________________ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.